Prolific Machines
Focus: Prolific Machines is a public biotechnology company developing a photomolecular platform for manufacturing difficult-to-produce proteins, with current focus on ophthalmology applications. The company has recently demonstrated manufacturing breakthroughs in monoclonal antibody production using light-controlled technology.
Profile data last refreshed 2h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
4
Should You Work at Prolific Machines?
AI assessmentProlific Machines offers a technical platform play with manufacturing differentiation, but career risk is high due to absent clinical pipeline, unclear commercial runway, and supply-chain-only hiring.
Why Work Here
- Platform technology with demonstrated manufacturing capability — May 2026 news highlights monoclonal antibody manufacturing record, suggesting differentiated technical competence.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Prolific Machines
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.